Title |
United airway disease: current perspectives
|
---|---|
Published in |
Journal of Asthma and Allergy, May 2016
|
DOI | 10.2147/jaa.s81541 |
Pubmed ID | |
Authors |
Pedro Giavina-Bianchi, Marcelo Vivolo Aun, Priscila Takejima, Jorge Kalil, Rosana Câmara Agondi |
Abstract |
Upper and lower airways are considered a unified morphological and functional unit, and the connection existing between them has been observed for many years, both in health and in disease. There is strong epidemiologic, pathophysiologic, and clinical evidence supporting an integrated view of rhinitis and asthma: united airway disease in the present review. The term "united airway disease" is opportune, because rhinitis and asthma are chronic inflammatory diseases of the upper and lower airways, which can be induced by allergic or nonallergic reproducible mechanisms, and present several phenotypes. Management of rhinitis and asthma must be jointly carried out, leading to better control of both diseases, and the lessons of the Allergic Rhinitis and Its Impact on Asthma initiative cannot be forgotten. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Korea, Republic of | 1 | <1% |
Unknown | 172 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 24 | 14% |
Researcher | 22 | 13% |
Other | 18 | 10% |
Student > Ph. D. Student | 17 | 10% |
Student > Master | 17 | 10% |
Other | 34 | 20% |
Unknown | 41 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 79 | 46% |
Immunology and Microbiology | 12 | 7% |
Agricultural and Biological Sciences | 11 | 6% |
Biochemistry, Genetics and Molecular Biology | 8 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
Other | 14 | 8% |
Unknown | 43 | 25% |